Clinical Trials
38 trialsHepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
Liver Disease and Other Systemic Diseases
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Mondelta
Hospices Civils de Lyon
MHALT
University of California, San Francisco
Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation
St. Louis University
MATCHES
H. Lee Moffitt Cancer Center and Research Institute
CLOVER
University of California, Davis
Utilization of MAsS in Patients Undergoing LT for HCC
Columbia University
Ablation of Hepatocellular Carcinoma: a Nationwide Study
Rigshospitalet, Denmark
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Chinese University of Hong Kong
RCT
Alexandria University
CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers
H. Lee Moffitt Cancer Center and Research Institute
ECHAPS
University Hospital, Grenoble
Possible Differences in HCC Course Depending on DAA Treatment
Medical University of Warsaw
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
University of Miami
Effect of DAAs on Behavior of HCC in HCV Patients
Al-Azhar University
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention
University of Texas Southwestern Medical Center
HEPCASUS
Karolinska Institutet
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
M.D. Anderson Cancer Center
STOP-HCC
University of Texas Southwestern Medical Center
A2ALL-2
Arbor Research Collaborative for Health
Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.
Austral University, Argentina
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening
Icahn School of Medicine at Mount Sinai
Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection
University of California, Irvine
A2ALL-1
Arbor Research Collaborative for Health
RECAR
Hospices Civils de Lyon
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Stanford University
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
ROLFH
University of Arkansas
Association Between Hepatitis C Infection and Renal Cell Carcinoma
Henry Ford Health System
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
Cairo University
Genetic Analysis of Liver Cancer
Stanford University
Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease
University Hospital Freiburg
Sonazoid Enhanced Liver Cancer Trial for Early Detection
Kindai University
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
National Cancer Institute, Milan
Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI
National Taiwan University Hospital